Literature DB >> 7003069

Computerized three-dimensional stereotaxic removal of small central nervous system lesions in patients.

S Jacques, C H Shelden, G D McCann, D B Freshwater, R Rand.   

Abstract

The authors describe the results of their recently reported computer-based stereotaxic surgical technique for the indentification, enhancement, three-dimensional reconstruction, localization, and removal of small central nervous system lesions. This technique has been applied to patients with various types of central nervous system pathology, and representative cases are reported.

Entities:  

Mesh:

Year:  1980        PMID: 7003069     DOI: 10.3171/jns.1980.53.6.0816

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  6 in total

1.  Neurosurgery with craniotomy and CT stereotactic guidance in the treatment of intracerebral space-occupying lesions.

Authors:  J F Hirsch; C S Rose; A Pierre-Kahn; D Renier; E Hoppe-Hirsch
Journal:  Childs Nerv Syst       Date:  1990-09       Impact factor: 1.475

2.  Diagnostic and therapeutic stereotactic cerebral endoscopy.

Authors:  J Caemaert; J Abdullah
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  A stereotactic guide for microsurgery. Technical note.

Authors:  L Steiner; C Lindquist
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

4.  Brain tumor resection guided by intraoperative computed tomography.

Authors:  D J Engle; L D Lunsford
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Correlation of neuropathologic findings, computerized tomographic and high-resolution ultrasound scans of canine avian sarcoma virus-induced brain tumors.

Authors:  R H Britt; B E Lyons; D R Enzmann; E L Saxer; S H Bigner; D D Bigner
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

Review 6.  The changing role of stereotaxis in surgical neuro-oncology.

Authors:  Mark E Linskey
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.